ArticleCancer management and research2026
Impact of Targeted Immune Checkpoint Inhibitor Adjuvant Therapy on Recurrence-Free Survival and Functional Recovery in Stage III Tongue Cancer Patients: A Retrospective Cohort Study.
Chengjie Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.